Cargando…
Tiao-Bu-Fei-Shen Formula Improves Glucocorticoid Resistance of Chronic Obstructive Pulmonary Disease via Downregulating the PI3K-Akt Signaling Pathway and Promoting GRα Expression
OBJECTIVE: To predict and determine the mechanism through which Tiao-Bu-Fei-Shen (TBFS) formula improves glucocorticoid resistance in chronic obstructive pulmonary disease (COPD), using network pharmacology, molecular docking technology, and in vitro studies. METHODS: The main active components and...
Autores principales: | Zhou, Pengcheng, Ma, Jianli, Yu, Wei, Chen, Keling, Zhang, Wensheng, Zhou, Jiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938767/ https://www.ncbi.nlm.nih.gov/pubmed/36820399 http://dx.doi.org/10.1155/2023/4359616 |
Ejemplares similares
-
Long-term effects of three Tiao-Bu Fei-Shen therapies on NF-κB/TGF-β1/smad2 signaling in rats with chronic obstructive pulmonary disease
por: Li, Ya, et al.
Publicado: (2014) -
Mechanism of Action of Bu-Fei-Yi-Shen Formula in Treating Chronic Obstructive Pulmonary Disease Based on Network Pharmacology Analysis and Molecular Docking Validation
por: Wu, Longchuan, et al.
Publicado: (2020) -
Bu-Fei Yi-Shen Granules Reduce Acute Exacerbations in Patients with GOLD 3–4 COPD: A Randomized Controlled Trial
por: Yu, Xue-Qing, et al.
Publicado: (2023) -
Mechanisms and Molecular Targets of BuShenHuoXue Formula
for Osteoarthritis
por: Xiong, Wen, et al.
Publicado: (2022) -
Bu-Fei decoction and modified Bu-Fei decoction inhibit the growth of non-small cell lung cancer, possibly via inhibition of apurinic/apyrimidinic endonuclease 1
por: Jiang, Shan-Tong, et al.
Publicado: (2018)